These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 2061103)
1. The Bethesda system for the reporting of cervical/vaginal cytology. Oren A; Fernandes J J Am Osteopath Assoc; 1991 May; 91(5):476-9. PubMed ID: 2061103 [TBL] [Abstract][Full Text] [Related]
2. Cervical cancer screening. Holcomb K; Runowicz CD Surg Oncol Clin N Am; 2005 Oct; 14(4):777-97. PubMed ID: 16226691 [TBL] [Abstract][Full Text] [Related]
5. [New classification in cervical cytology: the Bethesda system]. Bodó M; Tóth V Orv Hetil; 1991 May; 132(19):1039-40. PubMed ID: 2027678 [TBL] [Abstract][Full Text] [Related]
6. Value of repeat cytology at the time of colposcopy for the evaluation of cervical intraepithelial neoplasia on Papanicolaou smears. Wheelock JB; Kaminski PF J Reprod Med; 1989 Oct; 34(10):815-7. PubMed ID: 2795564 [TBL] [Abstract][Full Text] [Related]
7. False-negative cytology rates in patients in whom invasive cervical cancer subsequently developed. Morell ND; Taylor JR; Snyder RN; Ziel HK; Saltz A; Willie S Obstet Gynecol; 1982 Jul; 60(1):41-5. PubMed ID: 7088449 [TBL] [Abstract][Full Text] [Related]
8. The Bethesda system for classification of Pap smears: the clinical experience of one cancer screening center. Mahon SM Cancer Nurs; 1995 Dec; 18(6):458-66. PubMed ID: 8564942 [TBL] [Abstract][Full Text] [Related]
9. The pitfalls of cervical cancer screening. Sedlis A Contrib Gynecol Obstet; 1991; 18():103-14. PubMed ID: 1657521 [No Abstract] [Full Text] [Related]
10. Review of the screening history of Alberta women with invasive cervical cancer. Stuart GC; McGregor SE; Duggan MA; Nation JG CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389 [TBL] [Abstract][Full Text] [Related]
11. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology. Herbert A; Bergeron C; Wiener H; Schenck U; Klinkhamer P; Bulten J; Arbyn M Cytopathology; 2007 Aug; 18(4):213-9. PubMed ID: 17635161 [TBL] [Abstract][Full Text] [Related]
12. Changing cytologic detection rates for cervical intraepithelial neoplasia and invasive cancer in a population lacking a mass screening program. Frangopoulou E; Linos A; Mentzelopoulou P; Papaefthimiou M; Efstratiadou M Acta Cytol; 1989; 33(6):839-42. PubMed ID: 2588916 [TBL] [Abstract][Full Text] [Related]
13. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546 [TBL] [Abstract][Full Text] [Related]
14. Cervical cytology and the evaluation of the abnormal Papanicolaou smear. Noller KL Prim Care; 1988 Sep; 15(3):461-71. PubMed ID: 3054958 [TBL] [Abstract][Full Text] [Related]
15. Preliminary study concerning the cytoscreen system importance (liquid based cytology) in gynecologic cytology. Popescu CF; Bădulescu A; Bădulescu F; Cotarcea S; Găvănescu M Rom J Morphol Embryol; 2005; 46(1):23-7. PubMed ID: 16286981 [TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening in a rural population of Zimbabwe. Thistle PJ; Chirenje ZM Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642 [TBL] [Abstract][Full Text] [Related]
18. The 1988 Bethesda system for cervical vaginal cytology: pros and cons. Barlow JF S D J Med; 1991 Jun; 44(6):157-8. PubMed ID: 1658929 [No Abstract] [Full Text] [Related]
20. Cytodiagnosis in cervical neoplasia: from the Babes/Papanicolaou smear to the actual Bethesda System. Virtej P; Vasiliu C Clin Exp Obstet Gynecol; 2003; 30(4):173-7. PubMed ID: 14664403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]